Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Dong Sun

Showing results (301-310 of 305) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 305 results.
Pharmaceutics|September 20, 2019
Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain TumorsBabu V Sajesh, Ngoc H On, Refaat Omar, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 2, 2016
Comprehensive quantitative analysis of Chinese patent drug YinHuang drop pill by ultra high-performance liquid chromatography quadrupole time of flight mass spectrometryTin-Long Wong, Ya-Qi An, Bing-Chao Yan, et al.
Breast Cancer Research : BCR|July 12, 2014
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancerPatrick C O'Leary, Marta Terrile, Malgorzata Bajor, et al.
Nature Chemical Biology|April 10, 2012
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cellsChuan-Xu Liu, Qian-Qian Yin, Hu-Chen Zhou, et al.
Carbohydrate Polymers|July 23, 2021
A specific and bioactive polysaccharide marker for CordycepsLi-Feng Li, Grace Wing-Chiu But, Quan-Wei Zhang, et al.
Pageof 31

Showing results (301-310 of 305) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 305 results.
Pharmaceutics|September 20, 2019
Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain TumorsBabu V Sajesh, Ngoc H On, Refaat Omar, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 2, 2016
Comprehensive quantitative analysis of Chinese patent drug YinHuang drop pill by ultra high-performance liquid chromatography quadrupole time of flight mass spectrometryTin-Long Wong, Ya-Qi An, Bing-Chao Yan, et al.
Breast Cancer Research : BCR|July 12, 2014
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancerPatrick C O'Leary, Marta Terrile, Malgorzata Bajor, et al.
Nature Chemical Biology|April 10, 2012
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cellsChuan-Xu Liu, Qian-Qian Yin, Hu-Chen Zhou, et al.
Carbohydrate Polymers|July 23, 2021
A specific and bioactive polysaccharide marker for CordycepsLi-Feng Li, Grace Wing-Chiu But, Quan-Wei Zhang, et al.
Pageof 31